[1] Fisher B,Bryant J,Wolmark N,et al.Effect of preoperative chemotherapy on the outcome of women with operable breast cancer[J].J Clin Oncol,1998,16(8):2672-2785. [2] Bear HD.Neoadjuvant chemotherapy for operable breast cancer:individualizing locoregional and systemic therapy[J].Surg Oncol Clin N Am,2010,19(3):607-626. [3] Geng C,Chen X,Pan X.The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy:a systematic review and meta-analysis[J].PLoS One,2016,11(9):e0162605. [4] Mamounas EP,Brown A,Anderson S,et al.Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer:results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27[J].J Clin Oncol,2005,23(12):2694-2702. [5] Boughey JC.Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer[J].JAMA,2013,310(14):1455-1461. [6] Boughey JC,Ballman KV,Hunt KK,et al.Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery:results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance)[J].J Clin Oncol,2015,33(30):3386-3393. [7] Gradishar WJ,A.B.O.Balassanian R.Breast Cancer Version 2.2015[J].J Natl Compr Canc Netw,2015,33(3):448-475. [8] Zetterlund LH,Frisell J,Zouzos A,et al.Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer[J].Breast Cancer Res Treat,2017,163(1):103-110. [9] Boileau JF,Poirier B,Basik M,et al.Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer:the SN FNAC study[J].J Clin Oncol,2015,33(3):258-264. [10] Kuehn T,Bauerfeind I,Fehm T,et al.Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA):a prospective,multicentre cohort study[J].Lancet Oncol,2013,14(7):609-618. [11] Croshaw R,Shapiro-Wright H,Svensson E,et al.Accuracy of clinical examination,digital mammogram,ultrasound,and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients[J].Ann Surg Oncol,2011,18(11):3160-3163. [12] Liu S,Ren R,Chen Z,et al.Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy[J].J Magn Reson Imaging,2015,42(3):779-787. |